Acumen Pharmaceuticals, Inc. (ABOS) stock
Close on Nov 13, 2026Market cap $15.48MP/E –Yield –
Earnings
Acumen Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Acumen Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 25, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 26, 2026before the open | – | – | -$0.35 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 12, 2026before the open | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | May 12, 2026before the open | – | – | -$0.33 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 26, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025before the open | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025before the open | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 13, 2025before the open | – | – | -$0.48 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 27, 2025before the open | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 12, 2024before the open | – | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024before the open | – | – | -$0.34 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | – | – | -$0.25 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 19, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023before the open | – | – | -$0.24 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | – | – | -$0.28 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 9, 2023before the open | – | – | -$0.28 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 27, 2023before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022during market hours | – | – | -$0.26 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022during market hours | – | – | -$0.25 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 16, 2022during market hours | – | – | -$0.23 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 28, 2022during market hours | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 15, 2021before the open | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021during market hours | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Acumen Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Acumen Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Acumen Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Update
- Update
- Update
- Results
See a number that looks wrong?